COVID-19 severity is associated with worsened neurological outcomes in multiple sclerosis and related disorders
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
COVID-19 severity is associated with worsened neurological outcomes in multiple sclerosis and related disorders
Authors
Keywords
-
Journal
Multiple Sclerosis and Related Disorders
Volume 63, Issue -, Pages 103946
Publisher
Elsevier BV
Online
2022-06-07
DOI
10.1016/j.msard.2022.103946
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CSF Biomarkers in COVID-19 Associated Encephalopathy and Encephalitis Predict Long-Term Outcome
- (2022) Mar Guasp et al. Frontiers in Immunology
- Disease modifying therapies and Covid‐19 severity in Multiple Sclerosis
- (2021) Maria Pia Sormani et al. ANNALS OF NEUROLOGY
- 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
- (2021) Chaolin Huang et al. LANCET
- Frequency, signs and symptoms, and criteria adopted for long COVID: a systematic review
- (2021) Ana Luiza Cabrera Martimbianco et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Outcomes and Risk Factors Associated With SARS-CoV-2 Infection in a North American Registry of Patients With Multiple Sclerosis
- (2021) Amber Salter et al. JAMA Neurology
- COVID-19 as a Trigger of Brain Autoimmunity
- (2021) Mayuri Gupta et al. ACS Chemical Neuroscience
- Safety and efficacy of COVID-19 vaccines in multiple sclerosis patients
- (2021) Hannah Kelly et al. JOURNAL OF NEUROIMMUNOLOGY
- COVID-19 mRNA vaccination leading to CNS inflammation: a case series
- (2021) Mahsa Khayat-Khoei et al. JOURNAL OF NEUROLOGY
- Can coronavirus disease 2019 (COVID-19) trigger exacerbation of multiple sclerosis? A retrospective study
- (2021) Mahdi Barzegar et al. Multiple Sclerosis and Related Disorders
- COVID-19 and the Risk of Relapse in Multiple Sclerosis Patients: A Fight with No Bystander Effect?
- (2021) Masoud Etemadifar et al. Multiple Sclerosis and Related Disorders
- COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapies
- (2021) Afagh Garjani et al. Multiple Sclerosis and Related Disorders
- Ocrelizumab Extended Interval Dosing in Multiple Sclerosis in Times of COVID-19
- (2021) Leoni Rolfes et al. Neurology-Neuroimmunology & Neuroinflammation
- A clinical case definition of post-COVID-19 condition by a Delphi consensus
- (2021) Joan B Soriano et al. LANCET INFECTIOUS DISEASES
- Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis
- (2021) Steve Simpson-Yap et al. NEUROLOGY
- Frequency of Neurologic Manifestations in COVID-19
- (2021) Shubham Misra et al. NEUROLOGY
- Outcomes of COVID-19 infection in multiple sclerosis and related conditions: One-year pandemic experience of the multicenter New York COVID-19 Neuroimmunology Consortium (NYCNIC)
- (2021) Sylvia Klineova et al. Multiple Sclerosis and Related Disorders
- ¿ Can COVID-19 exacerbate multiple sclerosis symptoms? A case series analysis
- (2021) Gloria Michelena et al. Multiple Sclerosis and Related Disorders
- Symptoms after COVID-19 Infection in Individuals with Multiple Sclerosis in Poland
- (2021) Agata Czarnowska et al. Journal of Clinical Medicine
- Recovery From COVID-19 in Multiple Sclerosis
- (2021) Afagh Garjani et al. Neurology-Neuroimmunology & Neuroinflammation
- Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
- (2020) Victor M Corman et al. Eurosurveillance
- Viral and host factors related to the clinical outcome of COVID-19
- (2020) Xiaonan Zhang et al. NATURE
- Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry
- (2020) Carlos Manuel Romero-Sánchez et al. NEUROLOGY
- Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China
- (2020) Ling Mao et al. JAMA Neurology
- Serological Approaches for COVID-19: Epidemiologic Perspective on Surveillance and Control
- (2020) Cheryl Yi-Pin Lee et al. Frontiers in Immunology
- Persistent Symptoms in Patients After Acute COVID-19
- (2020) Angelo Carfì et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Neurological Involvement in COVID-19 and Potential Mechanisms: A Review
- (2020) Ghazal Aghagoli et al. Neurocritical Care
- COMPLICACIONES NEUROLÓGICAS EN PACIENTES CRÍTICOS POR SARS-CoV-2
- (2020) Maria Jose Abenza-Abildua NEUROLOGIA
- Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis
- (2020) Céline Louapre et al. JAMA Neurology
- Follow-up of adults with non-critical COVID-19 two months after symptoms' onset
- (2020) Claudia Carvalho-Schneider et al. CLINICAL MICROBIOLOGY AND INFECTION
- Serum Neurofilament Light Chain Levels in the Intensive Care Unit: Comparison between Severely Ill Patients with and without Coronavirus Disease 2019
- (2020) Raoul Sutter et al. ANNALS OF NEUROLOGY
- A Proposed Framework and Timeline of the Spectrum of Disease Due to SARS-CoV-2 Infection
- (2020) S. Deblina Datta et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- What can we learn from brain autopsies in COVID-19?
- (2020) Shibani S. Mukerji et al. NEUROSCIENCE LETTERS
- Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection
- (2020) Laurie G. Jacobs et al. PLoS One
- Variants in NLRP3 and NLRC4 inflammasome associate with susceptibility and severity of multiple sclerosis
- (2019) Jaine LS Soares et al. Multiple Sclerosis and Related Disorders
- Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
- (2018) Alan J Thompson et al. LANCET NEUROLOGY
- Causas no inflamatorias de consulta urgente en esclerosis múltiple
- (2018) L.A. Rodríguez de Antonio et al. NEUROLOGIA
- Multiple Sclerosis Relapses: Epidemiology, Outcomes and Management. A Systematic Review
- (2015) Tomas Kalincik NEUROEPIDEMIOLOGY
- Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study
- (2011) Harvey Moldofsky et al. BMC Neurology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now